Datum der Indexierung 04.10.2024 23:30:14
erkannte Namen Ria STAP | Norbert Heimberger | Asia Pacific |
Subdomain:
extern (outbound) Link/Domain 9 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description CSL Behring – a specialist in biotherapeutics for more than 100 years
Kombination Keywords behring more | first your | plasma plant | with award | approved approval | patients bern | treatment switzerland | factor immunglobulin | company rare | market production |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
Hizentra® The market licence for Hizentra® is issued and is valid in all 29 EU / EFTA member states for the treatment of people who have been diagnosed with primary or secondary immune deficiencies. 2011 FDA issues a license to expand the Hizentra® p Rhophylac® for ITP in the U.S. The U.S. Food and Drug Administration approves the treatment of immune thrombocytopenic purpura (ITP) as an additional indication for Rhophylac®. 2007 FDA approval for Privigen® The U.S. Food and Dru
Text Inhalt Text aus URL
Log Metriken 86083